Gene Query: FMOD

Dataset Description Geneva Score
RNA-seq of young and quiescent MRC-5 human fibroblasts 255.77
Differential gene expression in Jagged1 treated human dental pulp cells. 207.95
In vivo genome editing restores dystrophin expression in Duchenne muscular dystrophy patient muscle fibers 133.47
Expression level comparison under dividing and quiescent states in human primary fibroblasts 129.51
Reduced CYFIP1 in human neural progenitors as 15q11.2 deletion model: donor specific dysregulation of schizophrenia/epilepsy genes 125.17
Differential gene expressions in the heart of hypertrophic cardiomyopathy patients 119.88
Ectoderm specification of H1 human embryonic stem cells 95.86
Transcriptome-wide analysis of adipose circular RNAs reveals their dynamic regulation in obesity and functional role in adipogenesis 66.98
Reconstruction of the Human Blood-Brain Barrier in vitro reveals a Pathogenic Mechanism of APOE4 in Pericytes 64.67
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 61.23
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 54.22
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 54.22
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 51.75
Cerebellar differentiation in Ataxia-Telangiectasia 51.73
RNA-seq of human fibroblasts after irradiation 48.26
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 47.77
Gene expression analysis of the impact of TDP-43 knockout in human cells. 46.72
Modeling Trilateral Retinoblastoma using Human Embryonic Stem Cells 45.93
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 44.79
RNA sequencing of human fibroblasts after SUPT4H1 siRNA treatment 44.75
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 41.9
RNA sequencing of hPSC-derived cardiac progenitors and endocardium 36.84
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 35.57
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 35.57
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 32.23
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 32.23
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 29.79
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 29.79
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 29.62
Gene expression changes in human melanoma cell lines compared to primary melanocytes 29.61
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 28.96
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 28.91
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 28.25
Transcriptomic and gene ontology profiling of the human corneal cell types 27.24
Effect of Hotair overexpression in human breast cancer cell lines 26.57
CHD1 regulates cell fate determination by activation of differentiation-induced genes 26.41
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 26.06
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 25.04
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 25.03
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 25.03
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 24.54
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 23.54
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 23.54
Next Generation Sequencing of human SMA and healthy control Motor Neurons 23.36
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 23.19
Morphological and molecular characterization of human dermal lymphatic collectors 22.97
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 22.87
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 22.03
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 21.89
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 21.89
MicroRNA targetome analysis during HCMV infection 20.62
An acquired vulnerability of drug resistant melanoma with therapeutic potential 20.24
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 20.24
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription 20.21
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription [RNA-Seq] 20.21
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 19.99
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 19.75
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 19.65
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 19.61
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 19.56
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 19.27
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 19.06
Identifying deer antler proliferation and mineralization genes using comparative RNA-seq 18.65
Deep sequencing of transcript levels of human embryonic stem cell derived mesothelium (epithelial and mesenchymal forms) and mesothelium from neonatal mouse E15.5 of the heart, lung, liver and gut and ChIP-seq data of the mesenchymal form of mesothelium 18.64
ERBB3 and NGFR mark distinct skeletal muscle progenitor cells in human development enabling enrichment and maturation of hPSC muscle 17.99
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes 16.89
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 16.87
Gene expression analysis of a panel of human fibroblasts that generate an aligned (anisotropic) vs non-aligned extracellular matrix 16.84
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling 16.32
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 15.88
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 15.84
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 15.68
Age-Related Gene Expression Changes in Prostate Cancer Patients 15.68
Derivation and differentiation of haploid human embryonic stem cells [RNA-Seq 1] 15.61
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 15.37
Single cell transcriptome of peritoneal cells 15.16
Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia 15.12
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis: Expression data (RNA-seq) 14.89
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis 14.89
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 14.81
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 14.6
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 14.56
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 14.56
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 14.53
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 14.42
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 14.14
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 14.13
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 14.13
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 14.12
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription 14.12
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription.[RNA-seq and ChIP-seq] 14.12
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells II 14.07
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 13.99
Genome-wide expression analysis of young, senescent and p38MAPK-inhibitited senescent human fibroblasts. 13.79
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 13.65
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 13.56
Comparative analysis of mesenchymal stem cells derived from amniotic membrane, umbilical cord and chorionic plate under serum-free condition 13.53
RNA-Seq profiling of day 7 and day 18 kidney organoids differentiated in two batches 13.52
Gene expression profile difference among renal location in a stone former 13.49
Chromatin landscape of human visceral and subcutaneous adipocytes 13.48
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [RNA-Seq] 13.37
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [DNA Methylation] 13.37
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 13.2
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 13.2
High-efficiency RNA-based reprogramming of human primary fibroblasts 13.12
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 13.05
Gene profiling of human adult and pediatric liver cancer cells 13.03
mRNA differential expression analysis in a human ex vivo model of chronic wounds 12.76
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 12.61
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 12.59
A practical evaluation of alignment algorithms for RNA variant calling analysis 12.54
Crizotinib v. DMSO in SW480 cells 12.47
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 12.38
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 12.37
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 12.01
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 12.01
Maturation of human iNSCs 11.98
Mammalian Hbs1L deficiency causes Pelota depletion and is associated with a unique phenotype 11.96
Gene expression profiling of papillary thyroid cancer from central and invasive regions 11.95
Next Generation Sequencing Facilitates Quantitative Analysis of Human Pluripotent Stem Cell-Derived Endocardial-like And Primary Cardiac Endothelial Cell Transcriptomes 11.75
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 11.66
Total RNA sequencing of WT intestinal orgaonids. 11.59
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  11.59
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 11.58
Identification of global regulators of T-helper cell lineage specification 11.58
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 11.33
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma [RNA-Seq; normal samples] 11.21
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 11.2
11.17
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 11.07
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 11.01
Genome-wide profiling of siRNA targeting EWS-FLI1 in TC32 Ewing sarcoma cell line 10.96
Derivation and differentiation of haploid human embryonic stem cells 10.92
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 10.54
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 10.43
Transcriptional responses of melanoma cells to BRAF inhibition 10.35
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 10.26
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 10.22
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 10.2
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 10.04
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 9.91
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 9.88
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 9.84
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 9.74
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 9.7
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 9.7
RNA Sequencing of three pairs of gastric cancer 9.69
RNA-sequencing of human tendon after injury 9.62
STX4 Over-Expression in Human islets 9.41
PANCR, the PITX2 adjacent noncoding RNA, is specifically expressed in human left atria and regulates PITX2c expression 9.41
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 9.07
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 9.07
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 8.96
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype [RNA-seq] 8.9
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype 8.9
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 8.62
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 8.62
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 8.62
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 8.61
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 8.59
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 8.56
Total RNA-Seq data from leukemic patients with complex structural variants 8.5
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 8.5
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 8.5
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 8.42
Generation of trichogenic adipose-derived stem cells by expression of three factors 8.4
RNA-seq data of adipocytes co-cocultured with OVCAR5 in Boyden chamber (4d) 8.38
Large-scale profiling of intracellular signalling pathway activation reveals major distinctions between airway smooth muscle cells of asthmatics and non-asthmatics. 8.34
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 8.34
Transcriptome of human white and brown adipose tissue biopsies 8.32
Identification of gene signature in ascitic fluid-isolated mesothelial cells from high grade serous ovarian cancer patients 8.31
Investigation about fibroblasts of different origins in culture 8.3
Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders 8.24
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 8.23
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 8.22
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 8.15
mRNA-sequencing of breast cancer subtypes and normal tissue 8.13
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 8.02
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 7.76
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 7.61
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 7.57
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 7.57
Conversion of Human Fibroblasts to Stably Self-Renewing Neural Stem Cells with a Single Zinc-Finger Transcription Factor 7.51
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 7.5
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier 7.46
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier [human] 7.46
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 7.35
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 7.3
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 7.3
Novel Atherogenic Pathways from the Differential Transcriptiome Analysis of Diabetic Epicardial Adipose Tissue 7.29
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells 7.27
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 7.24
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 7.19
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma [RNA-Seq] 7.16
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma 7.16
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 7.12
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 7.12
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 7.09
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 7.09
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 7.09
High level DNA repair gene expression in human ES cells 7.04
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 6.96
Gene expression patterns define the hepatocyte-like cells derived by different strategies 6.93
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 6.93
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 6.9
Molecular analysis of renal cell carcinoma with unclassfied histology 6.9
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 6.87
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 6.87
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients 6.85
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 6.85
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 6.84
RNA-seq melanoma 6.67
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells 6.66
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 6.64
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes [RNA-Seq] 6.61
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes 6.61
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 6.59
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 6.53
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 6.53
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 6.5
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 6.42
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 6.39
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 6.39
Dynamic reorganization of nuclear architecture during human cardiogenesis 6.37
Dynamic reorganization of nuclear architecture during human cardiogenesis [RNA-seq] 6.37
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 6.36
Expression patterns in chronic thromboembolic pulmonary hypertension 6.32
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 6.27
The gene expression profiles of gallbladder cancer 6.18
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 6.15
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 5.93
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 5.89
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 5.83
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 5.83
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 5.77
Transcriptomic of MKD (MUC1 kidney disease) patient compares to normal derived kidney epithelial cells 5.74
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 5.74
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation 5.71
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 5.69
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 5.66
Comparing gene expression in iPSC derived RPE from control and AMD donors 5.62
Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging 5.58
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 5.54
Identification of mesothelial-to-mesenchymal gene signature in ascitic fluid-isolated mesothelial cells through RNA-sequencing 5.5
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 5.5
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells 5.48
Metabolism as an early predictor of DPSCs aging 5.46
Non-coding regions are the main source of tumor-specific antigens [human] 5.43
Non-coding regions are the main source of tumor-specific antigens 5.43
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 5.34
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 5.32
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 5.27
X-Ray induced DNA-Hydroxymethylation changes 5.27
Fibroblasts in cholesteatoma activate osteoclasts. 5.23
CHCHD10 gene KO effect in iPSC drived motor neurons 5.22
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 5.2
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 5.0
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 4.98
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 4.97
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 4.94
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 4.92
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 4.92
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 4.9
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 4.84
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 4.79
Endometrial transcriptome and PGR cistrome in cycling fertile women 4.78
Endometrial transcriptome and PGR cistrome in cycling fertile women [RNA-seq] 4.78
PGE2 mediated gene expression changes in human cervical stromal cells 4.77
DECIDUALIZATION INDUCES A SECRETOME SWITCH IN THE PERIVASCULAR NICHE CELLS OF THE HUMAN ENDOMETRIUM 4.73
Next Generation Sequencing identifying the dosage compensation state in human endometrial carcinoma and adjacent tissues 4.7
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 4.65
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 4.63
Postnatal lipids drive hepatocyte maturation 4.63
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 4.58
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 4.58
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 4.56
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 4.49
Select correlative genes involved in pathogenesis of idiopathic interstitial pneumonia by high-throughput sequencing analysis 4.41
Transcriptome analyses of human pancreatic islets and pseudoislets 4.4
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 4.39
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 4.37
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 4.3
Hepatic transcriptome of pediatric hepatoblastoma. 4.25
Dilated cardiomyopathy vs Myocarditis 4.17
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 4.06
Aortic Valve Tissue: Stenosis vs. Sclerosis 4.04
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 4.03
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 4.03
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 4.01
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling 4.01
The DNA methylation landscape of human melanoma 4.01
The DNA methylation landscape of human melanoma [RNA-Seq] 4.01
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 4.01
Tumor exosome integrins determine organotropic metastasis 3.99
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 3.98
Global gene expression differences between blood- and lymphatic-specific human dermal microvascular endothelial cells 3.95
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 3.93
Comprehensive RNA sequencing of healthy human endometrium at two time points of the menstrual cycle 3.91
Gene Expression Signature in Adipose Tissue of Acromegaly Patients 3.83
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 3.82
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 3.81
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 3.8
Measure transcript integrity using RNA-seq data 3.71
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 3.69
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 3.67
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 3.65
Three congruent human Schwann cell models of CMT1A reveal a converged phenotype 3.65
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 3.6
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 3.58
Identification of the role of polydom in neurofibromas 3.53
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 3.53
RNA-seq of stable and unstable section of human atherosclerotic plaques 3.51
RNA-seq analysis of the human fetal kidney. 3.5
The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing [RNA-seq] 3.47
Transcriptome profiling of the interconnection of pathways involved in malignant transformation and response to hypoxia 3.32
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 3.32
Expression profiling of lncRNAs, miRNAs and mRNAs and their differential expression in leiomyoma using next generation RNA sequencing 3.31
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 3.28
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 3.27
De novo reconstruction of human adipose reveals conserved lncRNAs as regulators of brown adipogenesis 3.21
Redifferentiation of expanded human islet β cells by inhibition of ARX 3.21
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 3.17
Gene expression profile of CRC-derived HILEC 3.17
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 3.16
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 3.14
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells I 3.09
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 3.05
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 3.04
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 3.03
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 3.03
Engineered human pluripotent stem cell-derived intestinal tissues with a functional enteric nervous system 2.98
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 2.96
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes 2.93
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes [RNA-seq] 2.93
Transcriptomic Profiling of Developing Human Paraxial Mesoderm from 4.5-5 Weeks of Gestation Human Embryos 2.93
Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function 2.9
The conserved transcriptional landscapes in human spermatogenesis 2.89
Modeling Human Cancer-induced Cachexia (Human) 2.87
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 2.86
Noncoding regions are the main source of targetable tumor-specific antigens 2.82
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 2.79
Expression profiling by RNA-Seq of breast cancer samples from patients in walnut-consuming and control groups 2.77
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 2.73
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 2.72
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 2.72
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 2.64
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 2.63
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 2.59
Transcriptomes in healthy and CHB fetal hearts 2.56
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 2.54
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 2.51
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 2.51
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 2.5
Gene expression of collecting duct carcinoma of the kidney 2.48
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 2.43
Gene expression profile of human iPSC-derived nephron progenitor cells 2.4
Transcriptome of invasive mucinous adnocarcinoma of the lung and adjacent normal lung tissues from 6 patients based on RNA-seq method 2.36
RNA-seq from primary skin fibroblasts, derived of matched pairs of middle and late donor age 2.33
Aging signatures developed from a longitudinal study design are dominated by reduced transcription of genes involved in protein synthesis. 2.33
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 2.33
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 2.31
Anti-Inflammatory Effects of Budesonide in Human Fetal Lung 2.28
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 2.26
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 2.25
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 2.25
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 2.24
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 2.23
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 2.21
RNA-seq identifies novel lncRNAs involved in vascular smooth muscle cell proliferation 2.19
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 2.13
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 2.11
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 2.03
Proteomics identifies a marker signature of MAPKi resistance in melanoma 1.99
mRNAseq of Huntington's disease and control patient iPSC-derived neural cells 1.99
Transcriptomic and Epigenomic analysis of Huntington's disease and control patient iPSC-derived neural cells 1.99
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 1.94
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 1.92
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 1.91
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 1.88
ELP1 splicing correction reverses proprioceptive sensory loss in familial dysautonomia 1.88
Effect of MDK expressing Melanoma cells conditioned media in Human LEC 1.85
An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch Type Alopecia Areata, Totalis and Universalis 1.84
RNAseq of Breast cancer PDX samples 1.82
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 1.82
Transcriptional profile in dermal fibroblasts from patients with collagen VI related muscular dystrophy 1.81
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 1.81
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 1.79
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 1.78
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 1.78
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 1.77
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 1.77
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 1.75
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 1.75
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 1.75
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 1.73
Expression by CD133+ cells isolated from the adult human exocrine pancreas 1.72
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 1.72
RNA-seq analysis and shRNA screen of breast cancer 1.71
RNA-seq analysis of breast cancer 1.71
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 1.69
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 1.69
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 1.67
Identification of a Cell-of-Origin for Fibroblasts Comprising the Fibrotic Reticulum in Idiopathic Pulmonary Fibrosis 1.63
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 1.61
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 1.6
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 1.6
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 1.57
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 1.57
Transcriptome Analysis and Functional Identification of Adipose-Derived Mesenchymal Stem Cells in Secondary Lymphedema 1.57
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 1.56
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 1.56
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 1.52
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 1.52
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 1.47
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 1.47
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 1.47
Random mono-allelic expression in MECP2-mutated cells 1.47
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 1.41
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 1.41
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 1.39
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 1.38
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 1.38
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 1.38
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 1.34
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations 1.33
Transcriptomic analysis of frontal fibrosing alopecia 1.33
CUREfast: Accelerating research with families 1.31
Screening in Human Cardiac Organoids Identifies a Requirement for the Mevalonate Pathway in Cardiomyocyte Proliferation 1.3
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 1.28
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 1.2
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 1.19
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 1.19
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 1.14
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 1.14
Epigenome regulation during epidermal lineage commitment [RNA-seq] 1.1
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 1.08
iPSC-Derived Cholangiocytes 1.07
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 1.06
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 1.04
Gene expression alterations of pancreatic intraepithlial neoplasia 1.03
Analysis of the senescent transcriptome upon expression of a ZFP36L1 phosphomutant 1.02
RNA-Seq and expression data from human adipose tissue 0.98
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.98
Gene expression activation in CLL mediated by MSCs contact 0.97
Transcriptional Profiling of Werner Syndrome (WS) iPSC-derived MSC and the isogenic gene-edited controls 0.95
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells 0.94
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells (RNA-seq) 0.94
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 0.93
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 0.85
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 0.8
Transcriptome analysis of eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps reveals distinct lncRNA expression profiles 0.72
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 0.7
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 0.68
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.67
OBESITY IS ASSOCIATED WITH IMPAIRED EXPRESSION OF THE GLYCOSYLTRANSFERASE EOGT IN DECIDUALIZING ENDOMETRIUM 0.65
Transcriptomes of iPSC-derived and post-mortum Hypothalamus Neurons from obese and control donors 0.65
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 0.62
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 0.59
The expression profiles of GBC liver metastasis 0.58
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 0.58
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] 0.57
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 0.57
Transcriptome analysis of diverse cell types infected with human cytomegalovirus 0.57
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 0.56
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.49
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 0.49
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 0.49
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 0.37
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 0.37
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 0.37
Engineering Patient-Specific Tissue Implants 0.35
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 0.33
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 0.3
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.29
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.29
RNA expression profiles comparing primary and omental ovarian carcinoma samples 0.29
mRNA-Seq profiling SIX2+ and Foxd1+ cells in mouse embryonic and SIX2+ and SIX2-/MEIS1+ cells human fetal kidney 0.26
p63 establishes epithelial enhancers de novo at critical craniofacial development genes 0.25
Expression profiling of converted and control dermal BJ fibroblasts 0.25
BMS-470539 on human synovial fibroblasts 0.23
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 0.21
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 0.21
Loss of endometrial plasticity in recurrent pregnancy loss 0.21
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 0.2
Transcriptome analysis of diverse cell types infected with human cytomegalovirus [RNA-Seq] 0.2
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 0.19
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 0.18
Glucose inhibits cardiac maturation through nucleotide biosynthesis 0.17
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 0.14
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 0.12
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 0.12
Progesterone Receptor- and FOXO1-dependent transcriptomes decidualized human endometrial stromal cells 0.1
Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells 0.1
FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization 0.1
RNA-seq in endometrial stromal tumors 0.07
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 0.06
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 0.03
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 0.02
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 0.02
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation